Skip to main content

The Canines-N-Kids Foundation is working to put an end to the cancers children and our canine best friends BOTH develop - devastating cancers including bone and brain cancer, lymphoma and leukemia.

Join us and help "CRUSH CANCER AT BOTH ENDS OF THE LEASH"!

Get Email Updates

 

LEARN MORE about Canines-N-Kids' mission and our programs. DOWNLOAD OUR BROCHURE

News & Events

OS Therapies, a research and clinical-stage biopharmaceutical company announced today the dosing of the "First Patient In" for its lead OST-HER2 (OST31-164) program in a potentially pivotal Phase IIb clinical trial. OST-HER2 has already received Fast-Track and Orphan Designation from the EMA and FDA. The nationwide open-label trial will enroll 39 to 45 Osteosarcoma patients whose cancer has metastasized to the lungs and has been surgically resected. OST-HER2 is targeting Osteosarcoma in children and young adults, and potentially other solid tumors.OST31-164 has previously received USDA provisional approval for treatment of Osteosarcoma in canines.

One Health’s FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

Grab two clean dog bowls, a can of whipped cream and your favorite canine friend and take part in something worthwhile and fun: the Canines-N-Kids Foundation’s #DogBowlChallenge to help #LickCancer!

 

Canines-N-Kids Foundation is a recognized 501c3 public charity. Our Federal Tax ID is 81-2768684

 

Powered by Firespring